Discover how NeuroQuant can provide your referring physicians with critical information about neurodegeneration identifiable in standard 3D T1-weighted brain images.
NeuroQuant is a breakthrough medical device that is the first FDA cleared, CE marked, and Health Canada licensed software for fully-automatic labeling, visualization and volumetric quantification of brain structures important in the assessment of neurodegenerative conditions from ages 3 to 100. The procedure may be reimbursed by Medicare under CPT 76377 and occurs wholly within your existing PACS infrastructure. Volumes and atrophy reports are automatically generated for your review prior to incorporating into your report. So, you can make quantitative segmental volume reporting and assessment a routine part of your analysis, without the need for a separate 3D processing lab.
Gone are the days of ambiguous, unhelpful and potentially misleading statements, such as “mild involutional changes” and “age-appropriate atrophy.” NeuroQuant will help you provide objective data back to the referring physician. With precise, volumetric data at your fingertips, you can: